NCT07351526

Brief Summary

Rehabilitation improves health outcomes, reduces disability and improves quality of life. There is a significant and emerging body of international evidence to support the benefit and cost effectiveness of specialist rehabilitation services within a modern health service. The demand for rehabilitation services is growing with changes in populations and with the advances in health care and new interventions and technology. Our overall aim is to explore the outcomes and clinical characteristics of adults who are admitted to a rehabilitation hospital in the Midwest region of Ireland during admission, at the time of their discharge and at 6 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Feb 2025Sep 2026

Study Start

First participant enrolled

February 22, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

December 8, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 22, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 22, 2026

Last Updated

January 20, 2026

Status Verified

October 1, 2025

Enrollment Period

1.6 years

First QC Date

December 8, 2025

Last Update Submit

January 9, 2026

Conditions

Keywords

rehabilitationcomplexityrehabilitation outcomes

Outcome Measures

Primary Outcomes (3)

  • Incidence of functional decline

    The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.

    Baseline

  • Incidence of functional decline

    The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.

    From the date on inception into the study until the date of discharge from hospital, assessed up to 6 months

  • Incidence of Functional Decline

    The number of participants who experience functional decline or do not as measured by the Barthel Index (BI). Functional decline is defined as a net decrease in the number of activities of daily living performed independently as measured by the self-reported BI. The sum of all of the 10 subscales of the BI ranges from 0-20 points where a higher score indicates increased independence.

    6 Months

Secondary Outcomes (12)

  • Healthcare use

    6 Months

  • Polypharmacy level

    Baseline

  • Polypharmacy level

    From the date on inception into the study until the date of discharge from hospital, assessed up to 6 months

  • Polypharmacy level

    6 Months

  • Frailty

    From the date on inception into the study until the date of discharge from hospital, assessed up to 6 months

  • +7 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adults admitted to St Ita's Rehabilitation Hospital from February 2025 to February 2026 (inclusive) will be considered eligible for participation in the study, if they meet the inclusion criteria.

You may not qualify if:

  • Pregnant women and patients who are deemed not to have capacity to consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Allied Health, University of Limerick

Limerick, Munster, V94 T9PX, Ireland

RECRUITING

Related Publications (2)

  • Zhang S, Lin D, Wright ME, Swallow N. Acute Inpatient Rehabilitation Improves Function Independent of Comorbidities in Medically Complex Patients. Arch Rehabil Res Clin Transl. 2022 Jan 12;4(2):100178. doi: 10.1016/j.arrct.2022.100178. eCollection 2022 Jun.

    PMID: 35756989BACKGROUND
  • Wang H, Camicia M, DiVita M, Mix J, Niewczyk P. Early inpatient rehabilitation admission and stroke patient outcomes. Am J Phys Med Rehabil. 2015 Feb;94(2):85-96; quiz 97-100. doi: 10.1097/PHM.0000000000000226.

    PMID: 25569470BACKGROUND

Related Links

MeSH Terms

Conditions

Frailty

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 8, 2025

First Posted

January 20, 2026

Study Start

February 22, 2025

Primary Completion (Estimated)

September 22, 2026

Study Completion (Estimated)

September 22, 2026

Last Updated

January 20, 2026

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Individual patient data collected during this study may be shared with approved researchers for the purpose of future research projects. Any data shared will be fully anonymised prior to release, with all direct and indirect identifiers removed to ensure that no participant can be identified. Only anonymised datasets will be made available, and these will be shared securely and solely for ethically approved research purposes.

Locations